Domus Diagnostics Moves Closer to Delivering Affordable At-Home Molecular Test for COVID-19, Flu-A, Flu-B and RSV

PARK CITY, Utah–(BUSINESS WIRE)–$2.4M contract from the NIH’s Rapid Acceleration of Diagnostics (RADx®) program accelerates development of ultra-low-cost, at-home diagnostic test
Click here to view original post